| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/2008 | CA2674378A1 Methods and compositions related to clot binding compounds |
| 07/17/2008 | CA2674356A1 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers |
| 07/17/2008 | CA2674315A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 07/17/2008 | CA2674228A1 Modified saccharides |
| 07/17/2008 | CA2674026A1 Methods of vaccine administration |
| 07/17/2008 | CA2673755A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 07/17/2008 | CA2663521A1 Combinatorial therapy of cancer and infectious diseases with anti-b7-h1 antibodies |
| 07/17/2008 | CA2663298A1 Alphavirus replicon particles as immunological adjuvants |
| 07/17/2008 | CA2661659A1 Smallpox monoclonal antibody |
| 07/16/2008 | EP1944371A2 Neisseria meningitidis antigens and compositions |
| 07/16/2008 | EP1944360A1 Method for culturing dendritic cells (DC) and cytokine-induced killer cells (D-CIK) and applications thereof |
| 07/16/2008 | EP1944322A2 Treatment of TNF alpha related disorders |
| 07/16/2008 | EP1944320A1 Immunoglobulin variants and uses thereof |
| 07/16/2008 | EP1944315A1 Prophylaxis and therapy of alzheimer's disease and other neurodementing diseases |
| 07/16/2008 | EP1944313A1 Recombinant malaria vaccine |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1944039A1 Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor |
| 07/16/2008 | EP1944038A1 Dengue virus capsid protein which induces a protective response and pharmaceutical composition |
| 07/16/2008 | EP1943517A2 Immunoassay of fragments of insulin-like growth factor binding proteins |
| 07/16/2008 | EP1943359A2 Compositions and methods for il13 biomarkers |
| 07/16/2008 | EP1943344A2 Methods for stimulating an immune response using bacterial antigen delivery system |
| 07/16/2008 | EP1943342A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 07/16/2008 | EP1943277A2 Anti-thrombotic agents |
| 07/16/2008 | EP1943269A2 Neisseria meningitidis antigens |
| 07/16/2008 | EP1942985A1 Methods for reducing blood pressure |
| 07/16/2008 | EP1942939A2 Interleukin-13 antibody composition |
| 07/16/2008 | EP1942937A1 Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| 07/16/2008 | EP1942936A2 Compositions and methods for treating inflammation |
| 07/16/2008 | EP1942935A2 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 07/16/2008 | EP1942934A1 Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| 07/16/2008 | EP1942933A2 Canine influenza vaccines |
| 07/16/2008 | EP1942932A2 Inactivating pathogens with hydrogen peroxide for vaccine production |
| 07/16/2008 | EP1942931A2 Preparation of vaccine master cell lines using recombinant plant suspension cultures |
| 07/16/2008 | EP1942927A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 07/16/2008 | EP1942926A2 Stem cell factor-like protein scfa1 and uses thereof |
| 07/16/2008 | EP1942924A2 Use of vaccines for the treatment/prevention of the transmission of influenza pathogens between species |
| 07/16/2008 | EP1814901B1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof |
| 07/16/2008 | EP1797175B1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 07/16/2008 | EP1687011B1 Modified whole cell, cell extract and omv-based vaccines |
| 07/16/2008 | EP1581812B1 Compositions and methods for diagnosing and treating colon cancers |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1334131B1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 07/16/2008 | EP1318835B1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 07/16/2008 | EP1311542B1 Tolerogenic peptides |
| 07/16/2008 | EP1292674B1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 07/16/2008 | EP1180123B1 Immunoconjugates having high binding affinity |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | EP1082134B1 Use of haptenised tumour cells and extracts thereof |
| 07/16/2008 | EP0951551B1 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 07/16/2008 | CN101223448A Pretreatment of a biological sample from an autoimmune disease subject |
| 07/16/2008 | CN101223445A Biomarkers for breast cancer |
| 07/16/2008 | CN101222937A Anti-HIV neutralizing active immune body or its fragment without resisting to IL-2 |
| 07/16/2008 | CN101222936A Inactivated chimeric and related methods of use |
| 07/16/2008 | CN101222935A Immunogenic composition |
| 07/16/2008 | CN101222926A Methods and compositions for treating or preventing cancer |
| 07/16/2008 | CN101220372A Recombined bifidobacteria -hRV/VP7 expression vector and oral administration vaccine thereof |
| 07/16/2008 | CN101220371A Recombined bifidobacteria hRV-VP4 expression vector and oral administration vaccine thereof |
| 07/16/2008 | CN101220370A Bifidobacteria-bacillus coli shuttle expression vector, preparation method and application thereof |
| 07/16/2008 | CN101220348A Pig replication and respiration syndrome virus attenuated vaccine strain and uses thereof |
| 07/16/2008 | CN101220337A Representation of HPV16 type recombinant protein vaccine for treatment by using pichia exudation |
| 07/16/2008 | CN101220098A Neutralizing antibodies against GDF-8 and uses therefor |
| 07/16/2008 | CN101220097A Monoclone antibody of H5 subtype avian influenza virus haemagglutinin protein, or its combination liveness fragment and uses thereof |
| 07/16/2008 | CN101220096A Preparation and application of humanized anti-spasmotoxin monoclone antibody |
| 07/16/2008 | CN101220086A Extraction, purification process for yersinia pestis natural F1 antigen |
| 07/16/2008 | CN101219217A Adjuvant composition and methods for its use |
| 07/16/2008 | CN101219216A Method for preparing coexpression PRRSV ORF3 and ORF5 double-gene nucleic acid vaccine |
| 07/16/2008 | CN101219215A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/16/2008 | CN101219214A Full sequence of similar tunica externa protein in adjacent river oyster richettsia and preparation of subunit vaccine |
| 07/16/2008 | CN101219205A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/16/2008 | CN100402660C Product quality enhancement in mammalian cell culture processes for protein production |
| 07/16/2008 | CN100402651C Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 07/16/2008 | CN100402643C 感染性克隆 Infectious clone |
| 07/16/2008 | CN100402554C Preparation and use of testes specificity protein 50 human source antibody |
| 07/16/2008 | CN100402551C Antigen epitope of beta2-microglobulin and its application |
| 07/16/2008 | CN100402090C Mucosa-immune composite adjuvant |
| 07/16/2008 | CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399840 Proteosome influenza vaccine |
| 07/15/2008 | US7399835 Cancerous disease modifying antibodies |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399825 Synthetic peptide, inhibitor to DNA viruses |
| 07/15/2008 | US7399740 Poly-Glu,Tyr for neuroprotective therapy |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399594 Preparing libraries of chimeric immunoglobulins which demonstrate increased specificity and are comprised of framework regions (FR) and for use as diagnostic and therapeutic tools; genetic vaccines; gene therapy |
| 07/15/2008 | US7399477 Genome segment, vaccine; temperature sensitivity, dominant interference, or attenuation; therapeutics, to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus |
| 07/15/2008 | US7399476 Nucleic acid free ghost preparations |
| 07/15/2008 | US7399474 Administering to a vertebrate an amount of a polynucleotide operatively encoding at least an immunogenic portion of the csa operon and having at least about 15 nucleotides; for prevention of enterotoxigenic e. coli colonization (diarrhea) |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399471 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood |
| 07/15/2008 | US7399470 Monoclonal antibodies produced by hybridomas via haptens |
| 07/15/2008 | US7399469 Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 07/15/2008 | US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 07/15/2008 | US7399467 Polyclonal and monoclonal antibodies bind to E6 proteins of oncogenic strains; kits for diagnosing cancer |
| 07/15/2008 | US7399466 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2183684C Inoculation of animals with dried, pelleted biological materials |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |